Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,032 | 113 | 98.7% |
| Education | $27.27 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $725.75 | 42 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $286.76 | 6 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $257.56 | 18 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $224.77 | 20 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $69.49 | 4 | $0 (2021) |
| ITI, Inc. | $68.91 | 4 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $65.01 | 4 | $0 (2024) |
| Axsome Therapeutics, Inc. | $62.79 | 2 | $0 (2024) |
| Lundbeck LLC | $51.08 | 2 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $49.81 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,290 | 72 | Vanda Pharmaceuticals Inc. ($286.76) |
| 2023 | $427.79 | 24 | ABBVIE INC. ($326.57) |
| 2021 | $340.96 | 18 | AbbVie Inc. ($119.84) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.12 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $14.64 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.77 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/02/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $33.45 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $37.48 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 12 | 45 | $6,750 | $2,518 |
| 2021 | 1 | 16 | 83 | $12,450 | $5,051 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 45 | $6,750 | $2,518 | 37.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 83 | $12,450 | $5,051 | 40.6% |
About Morgan Thomas
Morgan Thomas is a Mental Health healthcare provider based in Deland, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/15/2018. The National Provider Identifier (NPI) number assigned to this provider is 1992271134.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Morgan Thomas has received a total of $2,059 in payments from pharmaceutical and medical device companies, with $1,290 received in 2024. These payments were reported across 114 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,032).
As a Medicare-enrolled provider, Thomas has provided services to 28 Medicare beneficiaries, totaling 128 services with total Medicare billing of $7,569. Data is available for 2 years (2021–2022), covering 2 distinct procedure/service records.
Practice Information
- Specialty Mental Health
- Other Specialties Family, Psychiatric/Mental Health
- Location Deland, FL
- Active Since 10/15/2018
- Last Updated 04/03/2025
- Taxonomy Code 101YM0800X
- Entity Type Individual
- NPI Number 1992271134
Products in Payments
- VRAYLAR (Drug) $725.75
- REXULTI (Drug) $294.66
- Qelbree (Drug) $211.77
- HETLIOZ (Drug) $161.76
- CAPLYTA (Drug) $133.92
- FANAPT (Drug) $125.00
- LATUDA (Drug) $69.49
- Auvelity (Drug) $62.79
- JORNAY PM (Drug) $49.81
- QELBREE (Drug) $45.79
- TRINTELLIX (Drug) $42.93
- COBENFY (Drug) $41.91
- INGREZZA (Drug) $41.42
- INVEGA SUSTENNA (Drug) $25.47
- ARISTADA (Drug) $19.57
- ABILIFY ASIMTUFII (Drug) $6.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Mental Health Doctors in Deland
Kanisha Miller, Aprn, APRN
Mental Health — Payments: $450.38
Beverly Brim, Lmhc, LMHC
Mental Health
Ms. Lisa Pompa, Lmhc, LMHC
Mental Health
Henry Mccullough, Counselor, COUNSELOR
Mental Health
Miss. Sharon Hyles, Lmft, Lmhc, LMFT, LMHC
Mental Health
Ms. Deborah Rowland
Mental Health